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Abstract
Quinoa is a pseudo-grain consumed as a dietary staple in South America. In recent
years, consumer demand for quinoa in the developed world has grown steadily. Its
perceived health benefits have been cited as a driving force behind this trend, but
there are very few human studies investigating the impact of quinoa consumption.
The aim of this review was to identify physiological effects of quinoa consumption
with potential for human health. A critical evaluation of animal model studies was
conducted. The quality of identified studies was assessed using a methodological
quality assessment tool and summative conclusions were drawn to guide the direction
of future human research. The majority of studies were of fair quality. Purported
physiological effects of quinoa consumption included decreased weight gain,
improved lipid profile and improved capacity to respond to oxidative stress. These
physiological effects were attributed to the presence of saponins, protein and 20-
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hydroxyecdysone in the quinoa seed. The implications of these findings are that
human studies should investigate the impact of quinoa consumption on weight gain
and lipid levels. The role of quinoa as an antioxidant is still unclear and requires
further elucidation in animal models.
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DPPH

2,2-diphenyl-1-picrylhydrazyl

FRAP

Ferric reducing antioxidant power

HDL

High-Density Lipoprotein

LDL

Low-Density Lipoprotein

MQA

Methodological Quality Assessment

QI

Quality Index

RQ

Respiratory Quotient

2

Introduction
Across the globe, cereals form an integral part of the human diet, with an estimated
35% of daily dietary energy derived from this source [1]. Specifically, cereals
encompass grains, such as wheat and barley as well as pseudo-grains such as quinoa
and buckwheat [2]. Inclusion of the whole grain form of cereals in the diet is
associated with health benefits such as a reduction in the risk of developing
cardiovascular disease and diabetes [2]. These properties have contributed to the
establishment of dietary guidelines that encourage the regular consumption of whole
grains in the diet [3,4].
As a consequence of the health benefits that whole grains offer, research efforts have
begun to concentrate on specific grains and the role they could play in human
nutrition. Quinoa is an example of a pseudo-grain that has been grown in the Andes
and used for human consumption and livestock feed for thousands of years [5]. The
leading producers of quinoa are Peru and Bolivia [6], however there is emerging
global interest to produce quinoa as an alternative food crop [5]. Desirable agronomic
properties [7] in conjunction with higher prices induced by increased demand [8] have
been the drivers of this emerging interest.
As global awareness continues to grow, research efforts exploring the possible health
benefits associated with quinoa consumption become more valuable. Unique health
imparting properties increase the marketability of a food and are of interest to
manufacturers to pursue. As an example, quinoa protein, unlike most other grains, is
not limited by the amino acid lysine [9-11] creating a point of differentiation and
potential health advantage. In vitro experiments have shown that the digestibility of
starch from quinoa is similar to pasta and lower than white bread [12] while the

3

antioxidant potential is similar to wheat and superior to other so-called ancient grains
such as amaranth [13].
Reviews synthesising the literature surrounding quinoa have focussed on the nutrient
composition [14,7], as well as the functional potential of quinoa in the human diet [5].
Recently, it has been suggested that conducting systematic reviews of preclinical
studies, such as animal studies, is a valuable tool for establishing the likelihood of
mechanistic understanding being translated into human research applications [15]. In
particular, evaluating the validity of the methods underpinning these studies and the
results that are generated can determine hypotheses for future human studies. This is
relevant to quinoa as it is becoming an increasingly popular food, but its human health
benefits are relatively poorly researched. The primary aim of this review was to
identify physiological effects from quinoa consumption, which have potential for
human health benefits. The implications for research involving humans are discussed.

Method
A systematic review of the scientific literature was conducted according to published
standards. Since animal studies were the focus, the quality appraisal approach defined
by Downs and Black [16] and adjusted for use among animal studies by Ainge et al.
[17] was applied.
Inclusion and exclusion criteria
The eligibility criteria were determined prior to the commencement of the search so as
to minimise any bias in inclusion and exclusion of studies. All animal studies that
investigated the impact of quinoa consumption on physiological outcomes were
considered for inclusion. Included papers were limited to original research published
since 1975 in peer reviewed journals and published in the English language. Studies
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were excluded if they did not include quinoa as part of an experimental diet.
Previously conducted reviews were also excluded from this systematic review.
Search terms and strategy
“Quinoa”, “animal”, “health” and “feeding” formed the search terms. Combinations
of these terms were joined with the Boolean operator ‘AND’ to identify relevant
articles. The search encompassed the time period from 1975 onwards (40 year period)
and involved seeking relevant articles from the following electronic databases:
Agricola, Cambridge Journals Online, Cochrane Library, CINAHL, MEDLINE,
PubMed, SAGE Journals Online, ScienceDirect, Scopus, SPORTDiscus, Springer
Link, Web of Science and Wiley Online. The same set of search terms were used in
each database during the search phase, performed in February 2015.
Initially, the title of the article was examined for inclusion. Articles, which appeared
to be of relevance, were further reviewed through their abstract to determine if they
met the eligibility criteria. The full text of articles whose abstract met the criteria was
then saved and analysed to ensure the article met the inclusion criteria. The reference
lists of articles included for review were also examined for relevant articles. These
were assessed using the same eligibility criteria.
Data Extraction
Of the studies that met the inclusion criteria, the following information was extracted
into a summary table; animal species utilised, animal age, sample size, duration of the
experiment, the control and intervention diet/s, quinoa content in the intervention
diet/s, main findings and the quality of the article. The sample size reported in the
summary table was restricted to animals that were fed either the control or
intervention diet/s and was not necessarily equal to the sample size for the overall
experiment. Studies that presented significant findings in graphs without an explicit
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presentation of the effect size in a table (or in text) had their result summarised in the
summary table as being significantly different to their respective control.
Methodological quality assessment
The methodological design and validity of included studies were assessed by using a
modified version of the Quality Index (QI), developed by Downs and Black [16] and
adjusted for use among animal studies by Ainge et al. [17]. This modified tool, known
as the Methodological Quality Assessment (MQA), was refined further for this
systematic review to include all animal studies, rather than just studies utilising rats
(Fig. 1). The MQA provides a quantitative measure of study quality, enabling an
assessment of the rigour of individual studies to be made.
Of the 19 review questions, 12 assess the reporting quality, six the internal validity
and one the power of the studies. A ‘yes’ or ‘no’ response was reported as a one or
zero for each question respectively, with the total score determined by summing
together the answers to each of the 19 equally weighted questions. There were two
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Reporting
General
1. Were the hypothesis/aims/objectives of the study clearly described within the introduction?
2. Were the main outcomes to be measured clearly described in the introduction or methods section?
Animal characteristics
3. Was animal species/strain identified?
4. Was the animal age at commencement of the study or at conception specified?
5. Have the animal weights at commencement or at conception of the study been specified?
6. Have the animal starting numbers, including litter number and sizes been specified?
7. Have the housing details been specified?
Design and outcomes
8. Were the interventions of interest clearly described?
9. Were the main findings of the study clearly described?
10. Were estimates of the random variability in the data for the main outcomes provided?
11. Have all important adverse events that may be consequences of the intervention been reported?
12. Have the actual probability values been reported for the main outcomes except where probability value is less than 0.0001?

Internal validity
Bias
13. Was an attempt made to blind those measuring the main outcomes of the intervention?
14. Were the statistical tests used to assess the main outcomes appropriate?
15. Were the main outcomes measures used accurate (valid and reliable)?
Confounding
16. Was it stated in the text that the animals were randomised to intervention groups?
17. Was there adequate adjustment for confounding in the analyses from which the main findings were drawn?
18. Were loses of animals explained?
Power
19. Was the paper of sufficient power to detect a clinical important effect where the probability value for a difference being due to chance is less than 5%?

Fig. 1 Methodological Quality Assessment questions [17], modified from Downs and Black [16] Quality Index
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possible ways for a study to fulfil the criteria regarding power. Either an explicit power calculation was provided within the paper, or the study
identified a significant effect of the treatment with respect to the primary outcome. Reporting and internal validity scores were determined
separately and reported [17]. In a similar manner to previous work [18], individual study quality was categorised into four discrete quality levels
based on the overall score: excellent (17-19), good (14-16), fair (10-13) and poor (less than 10). Furthermore, responses to individual quality
questions across the included studies were summed in order to show general strengths and weaknesses across the literature.

Results
The systematic search of the scientific databases resulted in the identification of 888 articles for analysis. After eliminating articles that did not
fit the eligibility criteria, a total of 17 articles were included in the final review. Hand searching of the reference lists of the included articles
yielded an additional 2 articles (Fig. 2.) After the application of the eligibility criteria, one of these articles was appropriate to include in the
review. Therefore the combination of electronic and hand searching resulted in 18 articles being included for review.
The results from the MQA as well as the quality of the included studies were summarised in descending order (Table 1). The overall scores
ranged from 6 (poor) [9] to 14 (good) [19,20], with the average total score being 10.9 (fair). The vast majority of studies (12) were classified as
fair quality. Four were classified as being of poor quality, two as good and none as excellent quality. A summary of the reporting and internal
validity scores for each study is also provided in Table 1. Generally, the scores achieved in the reporting component of the MQA were superior
to the scores generated for the internal validity component across all the studies. Furthermore, the low internal validity scores were generally
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Table 1 A summary of the reporting, internal validity, total Methodological Quality
Assessment scores and study quality (excellent, good, fair or poor) attained by each
study as well as the average for these components across the body of literature
Reference

Quality

[20]
[19]
[21]
[22]
[23]
[24]
[11]
[25]
[26]
[27]
[28]
[29]
[30]
[31]
[10]
[32]
[33]
[9]
Average

Good
Good
Fair
Fair
Fair
Fair
Fair
Fair
Fair
Fair
Fair
Fair
Fair
Fair
Poor
Poor
Poor
Poor
Fair

Reporting
Score
(n/12)
9
11
9
10
9
9
8
8
8
8
9
9
7
8
7
7
8
5
8.3

Reporting
(%)
75
92
75
83
75
75
67
67
67
67
75
75
58
67
58
58
67
42
69

Internal
Validity Score
(n/7)
5
3
4
3
3
3
3
3
3
3
2
1
3
2
2
2
1
1
2.6

Internal
Validity (%)
71
43
57
43
43
43
43
43
43
43
29
14
43
29
29
29
14
14
37

Total
Score
(n/19)
14
14
13
13
12
12
11
11
11
11
11
10
10
10
9
9
9
6
10.9

Physiological outcomes that were comparatively assessed between animals consuming
quinoa and a control diet included weight gain and metabolic outcomes (16 studies),
lipid profiles (6 studies) and antioxidant effects (2 studies). Several studies examined a
combination of these outcomes, thus explaining the discrepancy between the number of
studies included in the review (18) and the number of studies showing physiological
outcomes (24).
Of the studies pertaining to weight gain, two were of good quality, ten of fair and four of
poor quality. The vast majority of studies showed a positive association between quinoa
consumption and decreased weight gain among animals. The largest effect was a
comparative decrease of 89% between the control and quinoa group [32]. The studies
that showed a comparative increase (of up to 10%) in weight gain among animals fed
quinoa were unable to show statistically significant increases. A general trend among the
studies investigating weight gain was for relative differences in weight gain between the
quinoa and control group to narrow as study quality declined. Three studies investigating
10

Table 2 A summary of the number and proportion of positive (yes) responses to each MQAa question for the 18 studies that were reviewed
3
17

4
10

5
10

6
15

7
17

8
15

9
17

10
18

11
0

12
1

Internal Validity
(Indication of Bias, Confounding & Power)
13
14
15
16
17
18
19
0
15
15
5
0
3
9

94

56

56

83

94

83

94

100

0

6

0

Reporting Quality
Item
1
2
14
15
Positive Response
Proportion of Positive
78
83
Responses (%)
a
Methodological Quality Assessment

83

83

28

0

17

50

Table 3 Summary of all studies reviewed
Reference

Animal
Species

[20]

Male
broilers
(ASA
Chick A/S)

[19]

Landrace
Yorkshire
Duroc

Animal
Age at
Start
6 days

Sample
Size
(n)
525

Trial
Length

Control
Diet

Intervention
Diet

Quinoa
in Diet
(g/kg)
100, 200,
400

31 days

Regular
broiler
feed

Regular
broiler feed
with raw or
processed
quinoa

0 days

960

39 days

Regular
broiler
feed

Regular
broiler feed
with raw or
processed
quinoa

50, 150

28 days

400

28 days

Basal
diet
without

Basal diet with
South
American or

0.1, 0.3,
0.5

Main
Outcome
Measure
Weight gain

Weight gain

Main Findings

Quality1

Control group gain – 1323g. Weight
gain (with increasing raw quinoa
content) 1247g (p>0.05), 1065g
(p<0.05) and 765g (p<0.05). Weight
gain (with increasing processed quinoa
content) 1232g (p>0.05), 1079g
(p>0.05) and 875g (p<0.05).
Control group gain after 20 days –
627g. Weight gain (group eating
150g/kg processed quinoa) 593g
(p<0.05) after 20 days. Weight gain did
not differ between groups at 39 days
(p>0.05).
Control group gain – 294g/day. Quinoa
groups gained 280-307g/day (p=0.41).
Jejunum epithelial conductance of

Good

Good

1

The quality of the studies (excellent, good, fair or poor) was based on the Methodological Quality Assessment score: excellent (17-19), good (14-16), fair (10-13) and poor
(less than 10)
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cross-bred
piglets
[21]

Wistar rats

quinoa
60 days

64

30 days

Rodent
chow
(Nuvilab
®)

Denmark
quinoa hull
meal
Nuvilab® with
hydrolysed
quinoa

2

Weight gain

Lipids

[22]

2

C57BL/6J
mice

6 weeks

36

3 weeks

1. Low
fat (LF)
diet
2. High
fat (HF)
diet

High fat diet
with added
quinoa extract
(HFQ)

Not
stated

Weight gain

control group – 22mS/cm2. In quinoa
groups, conductance was 24-25mS/cm2
(p=0.04).
Sedentary control group gain – 60.2g,
exercised control group gain – 94.2g.
Weight gain, (among quinoa fed
groups) sedentary – 16.5g (p<0.05) and
exercised – 60.0g (p<0.05)
Sedentary control group triglycerides –
92.9mg/dL, exercised control group –
63.1mg/dL. Triglycerides (among
quinoa fed groups) sedentary –
73.9mg/dL (p<0.05) and exercised –
60.9mg/dL (p>0.05).
Non-significant difference in
cholesterol between control and quinoa
group (p>0.05).
LF group gain – 3.0g. HF group and
HFQ group gain 5.1g (p<0.001) and
5.6g (p<0.001) respectively.
HF group epididymal adipose tissue
(EAT) – 28.8mg/g body weight. HFQ
EAT – 21.7mg/g body weight
(p<0.01).
HF group plasma leptin – 6.0ng/ml.
HFQ group plasma leptin – 3.9ng/ml
(p<0.05).
Plasma adiponectin and expression of
mRNA for SREBP-1c2 and PAI-1 were
lower in HFQ compared to LF group

Fair

Fair

SREBP-1c = Sterol Regulatory Element-Binding Proteins, PAI-1 = Plasminogen Activator Inhibitor-1
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(p<0.05).
Expression of mRNA for LPL3, PPARγ, PEPCK, Leptin, TLR4, MCP1,
CD68, GILZ, OST and PAI-1 were
lower in the HFQ group and mRNA
expression for UCP24 and UCP3 were
higher in HFQ group compared to the
HF group (all p<0.05).
Lipids

[23]

Male
Wistar rats

Not
stated

24

5 weeks

Corn or
corn with
31%
fructose

Quinoa or
quinoa with
31% fructose

310

Antioxidant
activity

[24]

Male
Wistar rats

Not
stated

24

5 weeks

Corn or
corn with
31%
fructose

Quinoa or
quinoa with
31% fructose

310

Lipids

[11]

Male

Not

15

4 weeks

Casein

1. Quinoa

680

Weight gain

LF and HF group triglycerides –
0.50g/l and 0.53g/l. HFQ group
triglycerides – 0.51g/l (p>0.05).
LF and HF group plasma cholesterol –
1.25g/l and 1.33g/l. HFQ group plasma
cholesterol – 1.35g/l (p>0.05).
The quinoa group had lower liver
GPX5 and CAT, lower CAT in the
testis and higher GPX in the spleen (all
p<0.05) compared to the corn control.
The quinoa with fructose group showed
lower MDA6 levels compared to the
corn with fructose group (p<0.01).
Cholesterol, triglycerides and LDL of
the quinoa group were significantly
lower (p<0.05, p<0.05, p<0.008
respectively) than levels in the corn
control group.
Control group gain – 57g. Weight gain

Fair

Fair

Fair

3

LPL = Lipoprotein Lipase, PPAR-γ = Peroxisome Proliferator-Activated Receptor-γ, PEPCK = Phosphoenolpyruvate Carboxykinase, TLR4 = Toll-Like Receptor 4, MCP-1
= Monocyte Chemoattractant Protein-1, CD68 = Cluster of Differentiation 68, GILZ = Glucocorticoid-induced Leucine Zipper, OST = Osteopontin
4
UCP2 = Uncoupling Protein 2, UCP3 = Uncoupling Protein 3
5
GPX = Glutathione peroxidase, CAT = Catalase
6
MDA = Malondialdehyde
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[25]

[26]

SpragueDawley
rats

stated

Male
Broiler
chicks

3 days

Male
Wistar-ST
rats

4 weeks

flour
2. Cooked
quinoa

90

28 days

Maize
diet
(13.2%
protein)
Maize
diet
(18%
protein)
Maize
diet
(13.3%
protein)

Raw or
polished
quinoa (13.2%
protein)
Raw or
polished
quinoa (18%
protein)
Raw, polished
or washed
quinoa (13.3%
protein)

953.5

90

28 days

120

14 days

120

31 days

Maize
diet
(23%
protein)

Raw, polished
or washed
quinoa (23%
protein)

800

10

13 days

Diet free
of quinoa

Control diet
with
methanolic
quinoa extract

11

Weight gain

835

962.5

Weight gain
Antioxidant
activity

for the quinoa flour group – 43g
(p>0.05) and for cooked quinoa group
– 89g (p<0.01).
Control group protein efficiency ratio
(PER) – 2.67. PER for quinoa flour
group – 2.09 (p<0.01) and 2.71
(p>0.05) for cooked quinoa group.
After 14 days, control group gain –
76g. Weight gain in raw and polished
quinoa group 64.2g and 67.6g
respectively (both p<0.05).
After 21 days, control group gain –
486.9g. Weight gain in raw and
polished quinoa group 118.6g and
210.1g respectively (both p<0.05).
After 7 days, control group gain –
87.5g. Weight gain in raw, polished
and washed quinoa group 53.0g
(p<0.05), 54.9g (p<0.05) and 92.9g
(p>0.05) respectively.
After 31 days, control group gain –
891.4g. Weight gain in raw, polished
and washed quinoa group 160.4g,
383.3g and 737.6g (all p<0.05)
respectively.
Control group gain – 14.5g. Quinoa
group gain – 15.1g (p>0.05).

Fair

Fair

Control and quinoa group serum αTocopherol – 8.5μg/ml and 5.6μg/ml
(p<0.05) respectively. Control group
serum and liver MDA 2.0nmol/mL and
33.3nmol/g respectively. Quinoa group
serum and liver MDA 3.0nmol/mL and
40.3nmol/g (both p<0.05) respectively.

14

[27]

[28]

7
8

Male Crj:
CD-1
(ICR) mice

Male
Wistar
Rats
(albino
strain)

7 weeks

Not
stated

18

16

4 weeks

15 days

0.5%
cholester
ol, 20%
casein

Casein

Control diet
with casein
substituted for
a quinoa
protein extract

25, 50

Quinoa in
place of casein

200

Weight gain

Lipids

Weight gain

No differences in serum or liver GPX
(p>0.05).
Control group gain – 11.28g. Weight
gain (with increasing quinoa extract)
12.02g and 10.78g (p>0.05).
Plasma cholesterol (0 to 5% quinoa)
268.2mg/dl, 199.9mg/dl (p<0.05),
204.5mg/dl (p<0.05). Liver cholesterol
(0 to 5%) quinoa 10.31mg/dl,
8.16mg/dl (p>0.05), 6.30mg/dl
(p<0.05).
Plasma triglycerides (0 to 5% quinoa)
84.5mg/dl, 55.4mg/dl, 45.2mg/dl
(p>0.05). Liver triglycerides (0 to 5%
quinoa) 14.06mg/g, 10.36mg/g,
9.24mg/g (p>0.05).
Daily faecal bile acid (0 to 5% quinoa)
125.8, 212.3 (p<0.05), 202.5μg/50g
body weight (p<0.05).
Expression of HMG-CoA7 reductase
was significantly lower (p<0.05) in the
quinoa groups than the control group.
No difference in weight gain between
control and quinoa group (p>0.05).
Control group and quinoa group
postprandial CCK8 levels 8.63ng/ml
and 12.56ng/ml (p<0.01) respectively.
No differences in fasting CCK, ghrelin
and leptin and postprandial ghrelin and
leptin between groups (p>0.05).

Fair

Fair

HMG-CoA reductase = 3-hydroxy-3-methylglutaryl coenzyme A
CCK = Cholecystokinin
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Lipids
[29]

Wistar rats

Not
stated

40

14 days

[30]

Y DY
commercia
l cross
piglets
Male
C57BL/6J
mice

8 weeks

144

5 weeks

6 weeks

Not
stated

3 weeks

[31]

Milled
and
cooked
wheat
cereal
Maize
and
wheat
meal
High fat
(HF) diet

Bitter, washed
bitter or sweet
quinoa
Maize and
wheat meal
with quinoa
High fat
quinoa (HFQ)
diet

862, 866,
873

Weight gain

50, 100

Weight gain

Control group gain – 294g/day. Weight
gain (with increasing quinoa content),
285g/day and 248g/day (both p>0.05).

Fair

2.8

Weight gain

Over a 24-hour period, the respiratory
quotient and glucose oxidation of the
HFQ group was higher than the control
group (both p<0.05). Control and HFQ
plasma leptin – 4.2ng/ml and 3.6ng/ml
(p>0.05) respectively.

Fair

Lipids

Control and HFQ plasma triglycerides
– 0.62g/L and 0.68g/L (p>0.05)
respectively. Over a 24-hour period,
HFQ faecal lipid content was higher
than control group (p<0.05).
Control and quinoa group gain – 130g
and 126g (p>0.05) respectively.
Control and quinoa group protein
efficiency ratio – 3.5 and 3.8 (p<0.05)
respectively.
Control and quinoa group gain –
11.0g/day and 1.2g/day respectively
(no statistics provided).
The quality of protein from quinoa was
poorer than the protein from the control

[10]

Rats

Not
stated

20

4 weeks

Corn
starch
with
casein

Dehulled
quinoa

641

Weight gain

[32]

Male
HoodedLister rats
Male
Sprague-

32 days

8

10 days

Basal diet with
quinoa

758

Weight gain

Not
stated

10

9 days

Basal
diet with
casein
Maize
starch

Not
stated

Weight gain

[33]

Maize starch
with quinoa

Cholesterol in the quinoa group was
significantly lower (p<0.01) than the
control group.
The control group gained more weight
than the bitter, washed bitter and sweet
quinoa groups (no statistics provided).

Fair

Poor

Poor
Poor
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[9]

Dawley
rats
Male
SpragueDawley
rats

Not
stated

Not
stated

9 days

with
casein
Maize
starch
with
casein

diet (no statistics provided).
Maize starch
with quinoa

Not
stated

Weight gain

Gain (in increasing order) was control
group, washed quinoa group and raw
quinoa group (no statistics provided).

Poor

weight gain also analysed the concentration of hormones involved in the regulation of appetite. The consumption of quinoa in the diet was
associated with a decrease in the concentration of plasma leptin by between 14% and 35% [31,22]. Post-prandial ghrelin and cholecystokinin
differences among the quinoa group were respectively 5.4% lower and 45.5% higher than levels among the control group [28]. In addition, one
of these studies investigated differences in the release of cytokines

(such as monocyte chemoattractant protein-1, interleukin-1β and

plasminogen activator inhibitor-1) from adipose tissue (adipokines) among mice fed high fat diets [22]. The addition of quinoa to the diet
decreased the mass of adipose tissue and significantly reduced the expression of inflammatory adipokines [22].
Six studies, all of fair quality, investigated the impact of quinoa consumption on lipids. Across the body of literature, the consumption of quinoa
was associated with decreases in cholesterol, triglycerides, low-density lipoprotein (LDL) and high-density lipoprotein (HDL). The largest
decreases in cholesterol, triglycerides and HDL were 25.5%, 46.5% and 9.6% respectively [27]. It was not possible to accurately quantify the
relative decreases in LDL levels because none of the studies reported the level of this biomarker in a tabular format. It did however appear that
as the concentration of quinoa in the diet rose above50g/kg so too did the efficacy of reductions in cholesterol, HDL and LDL. This apparent
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relationship between dose and effect did not appear to persist for decreases in
triglyceride levels.
Finally, the two studies investigating the antioxidant effects of quinoa were both of fair
quality. These studies measured the concentration of antioxidant compounds such as
glutathione peroxidase, catalase and superoxide dismutase as well as markers of
oxidative damage such as malondialdehyde. The expression of these antioxidant
compounds showed a vast degree of variability between organs and between animals
subjected to varying degrees of oxidative stress. Measures of lipid peroxidation between
the two studies were in complete contrast. The inclusion of quinoa in the diet resulted in
a decrease in lipid peroxidation by between 29.6% and 66.1% [23] but also a 21% to
50% increase in peroxidation compared to the control group [26].

Discussion
Among the included animal model studies, weight gain, lipid profiles and antioxidant
responses were the main physiological outcomes affected by quinoa consumption.
However, the body of literature supporting these effects showed wide variation in terms
of rigour and quality. The value of conducting a defined quality assessment for
evidence-based review was demonstrated here. Specifically, the MQA tool showed that
the quality of animal studies could be improved by incorporating design aspects such as
blinding, randomisation and power calculations. These methodological tools would help
minimise the impact of bias, including improved reporting on study design and
corresponding MQA score.
Effects on Weight Gain
Animal feeding experiments investigating quinoa as a potential food source have
identified the presence of saponins, which have been implicated in the reduction of
weight gain and feed consumption among animals [25]. There is however potential for
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saponins to play a role in human nutrition, particularly in developed countries, where
over nutrition is more widespread than under nutrition.
Across the body of literature, it appeared that the presence of saponins in quinoa was
connected to decreased weight gain. This association was replicated in rats, mice and
chickens and was achieved using a range of different dietary concentrations of quinoa. It
was however not replicated in two piglet studies [19,30], with speculation that the
concentration of saponins in the diet was too low to induce a significant change in
weight gain. More generally, it became apparent that as the methodological quality of
the studies decreased, so too did the detection of differences in weight gain between
treatment and control groups.
Despite the underlying weight loss effect, the magnitude of the effect varied across
studies, possibly due to the different concentration of saponins present in quinoa seeds.
Each variety of quinoa has a slightly different composition of saponins and each study
used processing techniques to prepare the intervention diet, which may have resulted in
the loss of saponin fractions. Evidence of these contrasting effects was seen in the two
good quality studies where saponins appeared to inhibit weight gain among chickens
[20] but had no effect among piglets [19]. Both studies used large sample sizes,
randomisation and employed a similar time period for the intervention to be performed.
The saponin content was however markedly lower in the latter study with piglets.
It was postulated that the mechanism through which saponins operate revolves around
their ability to interfere with intestinal function [29]. Studies in an Ussing chamber
showed that the presence of saponins derived from quinoa resulted in an increased
conductance of pig jejunum [19]. This finding suggests that there was an increase in the
permeability of the intestinal lining, resulting in a decreased capacity to actively absorb
nutrients for animal growth and development.
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The bitter taste of saponins has been implicated in reducing the palatability of certain
quinoa varieties. This was shown to decrease food intake [20,21,28,29] and was given as
an additional explanation for the incidence of decreased weight gain. A further rationale
for the decreased food intake may be due to changes in the expression of gut hormones
upon the consumption of quinoa. In particular, post-prandial cholecystokinin levels were
elevated after the consumption of quinoa [28], resulting in a feeling of satiety. Although
most commercially available quinoa has been processed to remove the bitter tasting
saponins, the presence of protein, dietary fibre and phenolics within the seed may be
capable of inducing feelings of satiety, assisting in the reduction of food intake and
weight gain.
The ability of quinoa to induce decreased weight gain was unable to be replicated among
mice fed a high fat diet with added quinoa [22]. Despite the null finding, the mice fed
quinoa showed a slight decrease in adipose tissue mass as well as a decrease in the
expression of lipid storage genes such as lipoprotein lipase and peroxisome proliferatoractivated receptor-γ [22]. The quinoa extract used in this study was rich in the naturally
occurring steroid hormone, 20-hydroxyecdysone. This compound is structurally similar
to Vitamin D, which has been shown to affect lipid accumulation in adipose tissue [22].
It was postulated that Vitamin D receptors formed suitable binding sites for 20hydroxyecdysone, enabling it to influence the expression of genes responsible for lipid
storage, however this mechanism requires further elucidation.
A recent follow up study suggested that the presence of 20-hydroxyecdysone in quinoa
was responsible for an increase in glucose oxidation and respiratory quotient (RQ)
among mice [31]. However, the explanation for the change in the RQ appears to be
counterintuitive. It was suggested that this was indicative of a decrease in fat oxidation
and decreased rate of de novo lipogenesis [31]. These both seem unlikely since levels of
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lipid oxidation among the quinoa and the control diet did not differ [31] and
furthermore, increased, rather than decreased de novo lipogensis from carbohydrate
would lead to an increase in the RQ value [34].
A high fat diet fed to mice was shown to increase the expression of inflammatory
cytokines released from adipose tissue [22]. This agrees with findings among
overweight and obese individuals that display elevated levels of inflammation due to the
release of cytokines from adipose tissue [35]. The addition of a quinoa extract rich in 20hydroxyecdysone to the high fat diet reversed the expression of inflammatory cytokines
to levels associated with a low fat diet. This effect may be due to a decrease in adipose
tissue mass among the quinoa group and therefore less capacity to release adipokines. It
may also be due to the action of 20-hydroxyecdysone and its metabolites binding
membrane receptors and as such influencing signal transduction and the expression of
adipokines. Future research should aim to identify the underlying cause, which is likely
to involve a complex interplay between these factors.
The concentration of quinoa needed to induce weight loss effects in a human cohort
must be explored in order to determine if the amount needed to achieve these effects is
attainable in the context of a regular diet. In addition, further studies investigating the
action of quinoa on weight gain should control the energy density by using isoenergetic
diets or calculate average energy intake by measuring the quantity of food consumed in
order to ascertain the effect of quinoa on weight gain independent of energy intake.
Identifying the potential for quinoa to influence weight gain is of such interest due to the
unacceptably high incidence of overweight and obesity; estimated to be 39% and 13% of
the global population respectively [36]. This represents a significant public health
burden, particularly since overweight and obesity are known risk factors for a chronic
diseases such as cardiovascular disease, Type 2 diabetes and some cancers [36].
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Effects on Lipid Profile
The studies investigating lipids were all of fair quality, and showed similarities in terms
of their weaknesses. Baseline measures were not explicitly reported, which is a basic
limitation of the findings. It could be argued that baseline measures among the animals
would not show significant variability due to the similarity in the ages and species of
animals. However, providing baseline measures would enable a comparison of changes
in lipid biomarkers between intervention and treatment diets to be performed. This
would be more informative than a comparison of levels at the completion of the study.
Despite this limitation, it was shown that the inclusion of quinoa in the diet had a
significant effect on cholesterol levels in as little as 15 days [28]. A similar acute
cholesterol lowering effect has been previously reported among humans consuming βglucan, where favourable outcomes were noted in as little as two weeks [37]. It was
proposed that proteins present within the quinoa seed facilitated a reduction in the reabsorption of bile acids and a reduction in hepatic cholesterol synthesis. This was
supported by findings that bile acid excretion was elevated and the expression of hepatic
HMG-CoA reductase was decreased among mice fed a quinoa diet [27]. This is a similar
mechanism to that indicated in other food components such as β-glucans [38], which are
effective at decreasing cholesterol [37].
The presence of 20-hydroxyecdysone in the outer casing of the quinoa seed has also
shown potential lipid lowering properties. In particular, it was implicated in causing
modifications to lipid absorption, which caused significantly higher levels of lipids to be
excreted in the faeces of mice fed a high fat diet supplemented with quinoa [31].
Additionally, the cholesterol lowering properties of quinoa were sustained when
hypercholesterolemia [27] and oxidative stress [24] were induced through the addition of
cholesterol and fructose to the diet respectively. Collectively, this suggests that quinoa
may play an active role in the metabolism of cholesterol.
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Based on the literature, it appears that the cholesterol lowering properties of quinoa only
become significant when at least 2.5% of the diet (2.5 grams per 100 grams) contains
quinoa [27]. In contrast, there is very little evidence to suggest that the concentration of
quinoa has an obvious impact on triglyceride levels. It appears that significant changes
in triglycerides are not observed until quinoa is consumed in the diet for at least 30 days
[21]. A greater understanding of the process occurring is therefore necessary before firm
conclusions can be drawn regarding quinoa and the impact on triglycerides.
None of the included studies were able to demonstrate that quinoa had a significant
impact on HDL, while only one study showed that a diet containing quinoa was able to
significantly lower LDL levels [24]. Interestingly, this study also had the highest dose of
quinoa and was performed over the longest time period. The tentative conclusions of
these findings are that consuming quinoa can reduce LDL over a longer time frame.
Extending the intervention period (beyond four or five weeks) may therefore lead to
additional improvements in the lipid profile. However, without the guidance of previous
work investigating quinoa consumption over a longer duration, it is difficult to
determine the optimum intervention period.
Heterogeneity in study design is likely to have played a part in generating the variable
outcomes. This heterogeneity included differences in animal species, animal ages,
quinoa content in the diet and duration of the intervention period. In addition, it was not
clear which bioactive compound/s were responsible for the underlying effects observed
in these studies. Animal studies should further investigate the lipid lowering effects
imparted by quinoa and attempt to refine the possible mechanisms that are in operation.
It is well established that high cholesterol levels are a risk factor for developing
cardiovascular disease [37]. Therefore, food products that can assist in improving the
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lipid profile in the human body, without radically altering the diet are extremely
desirable from a functional and nutritional perspective.
Antioxidant Effects
The antioxidant activity of quinoa has been previously investigated using validated
methods such as the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay and Ferric reducing
antioxidant power (FRAP) assay [39]. This review identified two animal studies that
explored the physiological effect of quinoa consumption on markers of oxidative stress
and concentration of antioxidant compounds.
The antioxidant properties of quinoa were most prominent during periods of oxidative
stress. Plasma lipid peroxidation was decreased while the expression of antioxidant
compounds such as glutathione peroxidase and catalase were elevated in several organs
[23]. This suggests that quinoa has the ability to regenerate antioxidant species that can
then attack free radicals and therefore protect tissues against oxidative damage.
However, these antioxidant properties were less clear when oxidative stress was not
intentionally induced in the diet. Since similar analytical methods were used to
determine lipid peroxidation, differences in study design are more likely to explain the
contrasting results. This includes the use of quinoa extracts that did not possess
antioxidant properties, short intervention periods and the use of vitamin supplements in
the control diet, which may have acted as antioxidants and nullified any advantageous
effects that were generated by consuming quinoa [26].
A limitation of both studies investigating the antioxidant potential of quinoa was the
absence of a detailed analysis (identification and quantification) of the main (bioactive)
compounds. Quinoa is known to possess compounds with strong antioxidant activity,
such as flavonoids and phenolic acids [39], however the presence of these compounds
was not assessed in either study despite the phytochemical composition of quinoa known
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to vary due to genetic and environmental factors. Additionally, there was no attempt to
determine the presence of potential in vivo metabolites in the blood, urine or faeces of
animals, which is crucial in understanding the in vivo bioactivity of compounds found in
plant foods such as quinoa. As a first step, future studies should determine the presence
of bioactive compounds followed by an assessment of the bioactivity of these
compounds.
It is well established that the consumption of foods rich in phytochemicals is associated
with a decrease in oxidative stress [40] and risk of mortality from cardiovascular disease
[41]. However, it is necessary to identify the specific phytochemicals present in the
quinoa seed and their relative bioactivity in order to begin to understand the potential
physiological benefits that they could impart upon consumption. This will provide a
more thorough understanding of their action and could be used to design experiments
that test their efficacy in a human population.
Limitations of Review
Throughout the design and completion of this literature review, steps were taken to
minimise the level of bias in the generation of the results. Despite these efforts, there are
several limitations that have been identified. Firstly, studies were included regardless of
their overall quality and as such, possible associations between dietary consumption and
physiological effects may have been under or overestimated. This was mitigated to a
certain degree by using a quality-rating tool, which provided a transparent guide to
ranking studies within the body of literature.
The second limitation refers to the doses consumed by animals in the respective studies.
It is difficult to infer the dose that would be appropriate in a human context and whether
dose dependency would persist, however, this is the critical issue and needs to be
addressed in any future human study. Additionally, this review treats studies that use
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isolated extracts, processed forms and raw forms of the quinoa seed as equally valid
dietary interventions. The weakness of this assumption is that humans eat foods and not
food extracts. Therefore it is difficult to predict the efficacy with which specific
compounds present in the quinoa seed would impact human health when consumed as
part of the diet. This is a limitation inherent in research exploring the effect of specific
compounds or nutrients. The underlying aim of this review however, was to identify
potential physiological effects of quinoa. Exploring the efficacy of quinoa in the whole
diet would be an appropriate procedure once these initial outcomes are identified.
Recommendations for Future Research
Animal studies provide a valuable tool for exploring the possible mechanisms that food
components operate through in delivering a health outcome. These types of studies
cannot be used to validate health claims within the regulatory context, but they can be
used to inform the design of future human clinical studies. Despite the heterogeneity
introduced through the use of differing animal models, doses of quinoa, sample sizes and
study time frames, it appears that the consumption of quinoa generates beneficial
physiological outcomes among animals.
The process of rating the quality of the individual studies is a prudent technique to
identify the underlying rigour with which the physiological effects were achieved. In
particular, there appeared to be a lack of blinding and randomisation in the majority of
studies, which should be addressed in future work. In addition the reliability of future
work could be improved by using larger samples, while the scope could be improved by
varying the dose of quinoa used in order to elucidate possible dose-dependent effects.
Based on the findings from this systematic review, human studies that investigate the
impact of quinoa with varying levels of saponins on weight gain would be a viable
experiment to perform. In addition, human studies could investigate the impact of
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quinoa consumption on the lipid profile. Despite the potential antioxidant properties
shown by quinoa, systematic analytical research using state of the art analytical
equipment such as HPLC-ESI-MS and NMR spectroscopy is required to identify and
quantify the main bioactive compounds in quinoa before human studies can be justified.

Conclusion
This systematic review of the animal model literature has identified that the
consumption of quinoa may lead to comparatively lower weight gain, an improved lipid
profile and potential antioxidant effects. These physiological outcomes require further
investigation, with a particular focus on elucidating the mechanism through which
bioactive compounds, such as saponins, quinoa proteins, polyphenolic compounds and
20-hydroxyecdysone operate to deliver these desirable outcomes.
Despite the limitations of the animal studies that have been performed to date, there is
burgeoning interest in quinoa as a food source and a steady uptake of it in the diet. To
add further substance to the health properties that quinoa is perceived to possess,
rigorously controlled human studies that aim to investigate the three key outcomes
identified in this review should be performed. The identification of health benefits in a
human population would encourage further investment in quinoa and galvanise public
perception that it is a desirable food that could be consumed as part of a balanced diet.
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